Category: Technology Licenses
Created On: 2022-04-28
Record Count: 8
- Skin care
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 2512
IPSCIO Record ID: 2369
IPSCIO Record ID: 393
Licensed Patents means (i) U.S. Patent No. 5,895,784, entitled Method for Treatment of Cancer by Oral Administration of Modified Pectin; (ii) U. S. Patent No. 5,834,442, entitled Method for Inhibiting Cancer Metastasis by Oral Administration of Soluble Modified Citrus Pectin; (iii) any U.S. patent application filed as a continuation, continuation-in-part or division of the patents or patent applications, (iv) any foreign applications or patents which are counterparts to the U.S. patents; (v) any foreign applications or patents which are counterparts to the U.S. patents and (vi) any patents which issue from applications. The Company and University agreed to a license and patents for cancer drug. Now in phase 2 clinical trials for pancreatic and colorectal cancers, the drug, called GBC-590.
IPSCIO Record ID: 26125
IPSCIO Record ID: 25940
The technology company is about half way through U.S. regulatory testing of its modified silicon product BioSilicon that allows tiny pieces of radioactive material to be directly injected into primary liver tumours, as opposed to traditional radiotherapy that involves hitting a broader area with radiation.
i) interstitially within a cancerous tumour;
ii) into a resection cavity after surgical removal of a cancerous tumour;
iii) into the peritoneal cavity; or
iv) via the vasculature ( to the extent it becomes technically feasible).
IPSCIO Record ID: 1977
IPSCIO Record ID: 359135
IPSCIO Record ID: 221650
The product candidate pipeline consists of late-stage branded product candidates that leverage the proprietary, silica-based microencapsulation technology platform, and several generic product candidates across multiple indication.
Licensor is a dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases.